Comparative hepatic gene expression profiling of rats treated with 1H,1H,2H,2H-heptadecafluorodecan-1-ol or with pentadecafluorooctanoic acid

Physiological Genomics

Volumn 34, Issue 3, 2008, Pages 285-303

  Nilsen, Anja Julie ^a   Landin, Maria A ^a   Haug, Kristin H ^a   Fonnum, Frode ^a,b   Berger, Urs ^c   Osmundsen, Harald ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b NORWEGIAN DEFENCE RESEARCH ESTABLISHMENT FFI   (Norway)

^c NORWEGIAN INSTITUTE FOR AIR RESEARCH   (Norway)

Author keywords

Fatty acid; Lipid; Liver; Mitochondria; Peroxisome; Signaling; Xenobiotic

Indexed keywords

1H,1H,2H,2H HEPTADECAFLUORODECAN 1 OL; DECANOL; OCTANOIC ACID; PENTADECAFLUOROOCTANOIC ACID; PEROXISOME PROLIFERATOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; GENE EXPRESSION; GENE SEQUENCE; GENE SYNTHESIS; MALE; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; FLUOROCARBONS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; LIVER; MALE; OCTANOIC ACIDS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGAN SIZE; PHENOTYPE; RATS; RATS, WISTAR; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SOFTWARE;

RATTUS;

EID: 57049090694     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00225.2007     Document Type: Article

References (32)

1. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 57: 289-300, 1995.
2. Berger U, Langlois I, Oehme M, Kallenborn R. Comparison of three types of mass spectrometers for HPLC/MS analysis of perfluoroalkylated substances and fluorotelomer alcohols. Eur J Mass Spectrom (Chichester) 10: 579-588, 2004.
3. Berthiaume J, Wallace KB. Perfluorooctanoate, perfluorooctanesulfonate, and N-ethyl perfluorooctanesulfonamido ethanol; peroxisome proliferation and mitochondrial biogenesis. Toxicol Lett 129: 23-32, 2002.
4. Brandt E, Heymann E, Mentlein R. Selective inhibition of rat liver carboxylesterases by various organophosphorus diesters in vivo and in vitro. Biochem Pharmacol 29: 1927-1931, 1980.
5. Cheadle C, Vawter MP, Freed WJ, Becker KG. Analysis of microarray data using Z score transformation. J Mol Diagn 5: 73-81, 2003.
6. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4: P3, 2003.
7. Derbel M, Hosokawa M, Satoh T. Differences in the induction of carboxylesterase RL4 in rat liver microsomes by various perfluorinated fatty acids, metabolically inert derivatives of fatty acids. Biol Pharm Bull 19: 765-767, 1996.
8. Eberle D, Hegarty B, Bossard P, Ferre P, Foufelle F. SREBP transcription factors: master regulators of lipid homeostasis. Biochimie 86: 839-848, 2004.
9. Eliassen K, Osmundsen H. Factors which may be significant regarding regulation of the clofibrate-dependent induction of hepatic peroxisomal beta-oxidation and hepatomegaly. Biochem Pharmacol 33: 1023-1031, 1984.
10. Fromme H, Midasch O, Twardella D, Angerer J, Boehmer S, Liebl B. Occurrence of perfluorinated substances in an adult German population in southern Bavaria. Int Arch Occup Environ Health 80: 313-319, 2007.
11. Giesy JP, Kannan K. Global distribution of perfluorooctane sulfonate in wildlife. Environ Sci Technol 35: 1339-1342, 2001.
12. Giesy JP, Kannan K, Jones PD. Global biomonitoring of perfluorinated organics. Scientific World Journal 1: 627-629, 2001.
13. Guruge KS, Yeung LW, Yamanaka N, Miyazaki S, Lam PK, Giesy JP, Jones PD, Yamashita N. Gene expression profiles in rat liver treated with perfluorooctanoic acid (PFOA). Toxicol Sci 89: 93-107, 2006.
14. Hekster FM, Laane RW, de Voogt P. Environmental and toxicity effects of perfluoroalkylated substances. Rev Environ Contam Toxicol 179: 99-121, 2003.
15. Henderson WM, Smith MA. Perfluorooctanoic acid and perfluorononanoic acid in fetal and neonatal mice following in utero exposure to 8-2 fluorotelomer alcohol. Toxicol Sci 95: 452-461, 2007.
16. Holden PR, Tugwood JD. Peroxisome proliferator-activated receptor alpha: role in rodent liver cancer and species differences. J Mol Endocrinol 22: 1-8, 1999.
17. Huhtinen K, O'Byrne J, Lindquist PJ, Contreras JA, Alexson SE. The peroxisome proliferator-induced cytosolic type I acyl-CoA thioesterase (CTE-I) is a serine-histidine-aspartic acid alpha/beta hydrolase. J Biol Chem 277: 3424-3432, 2002.
18. Ikeda T, Aiba K, Fukuda K, Tanaka M. The induction of peroxisome proliferation in rat liver by perfluorinated fatty acids, metabolically inert derivatives of fatty acids. J Biochem (Tokyo) 98: 475-482, 1985.
19. Inoue I, Katayama S. The possible therapeutic actions of peroxisome proliferator-activated receptor alpha (PPAR alpha) agonists, PPAR gamma agonists, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, angiotensin converting enzyme (ACE) inhibitors and calcium (Ca)-antagonists on vascular endothelial cells. Curr Drug Targets Cardiovasc Haematol Disord 4: 35-52, 2004.
20. Jevnaker AM, Osmundsen H. MicroRNA expression profiling of the developing murine molar tooth germ and the developing murine submandibular salivary gland. Arch Oral Biol 53: 629-645, 2008.
21. Kogure K, Ishizaki M, Nemoto M, Kuwano H, Makuuchi M. A comparative study of the anatomy of rat and human livers. J Hepatobiliary Pancreat Surg 6: 171-175, 1999.
22. Kudo N, Suzuki-Nakajima E, Mitsumoto A, Kawashima Y. Responses of the liver to perfluorinated fatty acids with different carbon chain length in male and female mice: in relation to induction of hepatomegaly, peroxisomal beta-oxidation and microsomal 1-acylglycerophosphocholine acyltransferase. Biol Pharm Bull 29: 1952-1957, 2006.
23. Maras M, Vanparys C, Muylle F, Robbens J, Berger U, Barber JL, Blust R, De Coen W. Estrogen-like properties of fluorotelomer alcohols as revealed by mcf-7 breast cancer cell proliferation. Environ Health Perspect 114: 100-105, 2006.
24. Martin JW, Mabury SA, O'Brien PJ. Metabolic products and pathways of fluorotelomer alcohols in isolated rat hepatocytes. Chem Biol Interact 155: 165-180, 2005.
25. Nordstoga K, Christophersen B, Ytrehus B, Espenes A, Osmundsen H, Landsverk T, Olivecrona T, Olivecrona G. Pancreatitis associated with hyperlipoproteinaemia type I in mink (Mustela vison): earliest detectable changes occur in mitochondria of exocrine cells. J Comp Pathol 134: 320-328, 2006.
26. Osmundsen H, Bremer J, Pedersen JI. Metabolic aspects of peroxisomal beta-oxidation. Biochim Biophys Acta 1085: 141-158, 1991.
27. Pfaffl MW, Georgieva TM, Georgiev IP, Ontsouka E, Hageleit M, Blum JW. Real-time RT-PCR quantification of insulin-like growth factor (IGF)-1, IGF-1 receptor, IGF-2, IGF-2 receptor, insulin receptor, growth hormone receptor, IGF-binding proteins 1, 2 and 3 in the bovine species. Domest Anim Endocrinol 22: 91-102, 2002.
28. Renner R. Sorting out sources of perfluorinated chemicals. Environ Sci Technol 40: 2866-2867, 2006.
29. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132: 365-386, 2000.
30. Sim AK, Spencer A, Metz G, Rushton B. Effect of hypolipidaemic drugs on hepatomegaly and micro-bodies in the rat. A new approach to the nature of hepatic peroxisomal proliferation. Arzneimittelforschung 31: 1119-1126, 1981.
31. Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Barbee BD, Richards JH, Butenhoff JL, Stevenson LA, Lau C. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations. Toxicol Sci 74: 369-381, 2003.
32. Upham BL, Deocampo ND, Wurl B, Trosko JE. Inhibition of gap junctional intercellular communication by perfluorinated fatty acids is dependent on the chain length of the fluorinated tail. Int J Cancer 78: 491-495, 1998.